Development of a Commercial Process for Deucravacitinib, a Deuterated API for TYK2 Inhibition
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of a Commercial Process for Deucravacitinib, a Deuterated API for TYK2 Inhibition
Authors
Keywords
-
Journal
ORGANIC PROCESS RESEARCH & DEVELOPMENT
Volume -, Issue -, Pages -
Publisher
American Chemical Society (ACS)
Online
2022-02-18
DOI
10.1021/acs.oprd.1c00468
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of N-Methyl Nicotinamide and N-Methyl Pyridazine-3-Carboxamide Pseudokinase Domain Ligands as Highly Selective Allosteric Inhibitors of Tyrosine Kinase 2 (TYK2)
- (2019) Ryan Moslin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Highly Selective Inhibition of Tyrosine Kinase 2 (TYK2) for the Treatment of Autoimmune Diseases: Discovery of the Allosteric Inhibitor BMS-986165
- (2019) Stephen T. Wrobleski et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mutagenic Impurities in 1-Hydroxybenzotriazole (HOBt)
- (2019) Daniel S. Treitler et al. ORGANIC PROCESS RESEARCH & DEVELOPMENT
- Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study
- (2018) Ronald F van Vollenhoven et al. LANCET
- Design and evolution of the BMS process greenness scorecard
- (2017) David K. Leahy et al. GREEN CHEMISTRY
- Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparator–controlled VOYAGE 1 trial
- (2017) Andrew Blauvelt et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
- (2017) Daniella M. Schwartz et al. NATURE REVIEWS DRUG DISCOVERY
- Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus
- (2017) Richard Furie et al. Arthritis & Rheumatology
- Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study
- (2016) Munther Khamashta et al. ANNALS OF THE RHEUMATIC DISEASES
- Applications of Palladium-Catalyzed C–N Cross-Coupling Reactions
- (2016) Paula Ruiz-Castillo et al. CHEMICAL REVIEWS
- CHEM21 selection guide of classical- and less classical-solvents
- (2016) Denis Prat et al. GREEN CHEMISTRY
- Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
- (2016) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity
- (2016) C. A. Dendrou et al. Science Translational Medicine
- Type I/II cytokines, JAKs and new strategies for treating autoimmune diseases
- (2015) Daniella M. Schwartz et al. Nature Reviews Rheumatology
- Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases
- (2014) James D. Clark et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis of Akt Inhibitor Ipatasertib. Part 1. Route Scouting and Early Process Development of a Challenging Cyclopentylpyrimidine Intermediate
- (2014) Jonathan W. Lane et al. ORGANIC PROCESS RESEARCH & DEVELOPMENT
- Current Developments in the Syntheses of 1,2,4-Triazole Compounds
- (2013) Hui-Zhen Zhang et al. CURRENT ORGANIC CHEMISTRY
- Process Development and Multikilogram-Scale Synthesis of a TRPV1 Antagonist
- (2013) Ed Cleator et al. ORGANIC PROCESS RESEARCH & DEVELOPMENT
- Development of an Efficient and Practical Route for the Multikilogram Manufacture of Ethyl 5-Cyano-2-methyl-6-oxo-1,6-dihydropyridine-3-carboxylate and Ethyl 6-Chloro-5-cyano-2-methylnicotinate, Key Intermediates in the Preparation of P2Y12 Antagonists
- (2012) Stephen J. Bell et al. ORGANIC PROCESS RESEARCH & DEVELOPMENT
- Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility
- (2011) N. Couturier et al. BRAIN
- Ustekinumab
- (2011) Jamie D. Croxtall DRUGS
- Studies on pyrazine derivatives LII: Antibacterial and antifungal activity of nitrogen heterocyclic compounds obtained by pyrazinamidrazone usage
- (2011) Henryk Foks et al. HETEROATOM CHEMISTRY
- Synthesis ofN-Substituted 1,2,4-Triazoles. A Review
- (2011) Stefanie C. Holm et al. ORGANIC PREPARATIONS AND PROCEDURES INTERNATIONAL
- Type I interferons in systemic autoimmunity
- (2010) Silvano Sozzani et al. AUTOIMMUNITY
- Synthesis of 3,4,5-Trisubstituted-1,2,4-triazoles
- (2010) Aline Moulin et al. CHEMICAL REVIEWS
- Hydrolysis of Phosphoryl Trichloride (POCl3): Characterization, in Situ Detection, and Safe Quenching of Energetic Metastable Intermediates
- (2010) Michał M. Achmatowicz et al. ORGANIC PROCESS RESEARCH & DEVELOPMENT
- Dialkylbiaryl phosphines in Pd-catalyzed amination: a user's guide
- (2010) David S. Surry et al. Chemical Science
- Evolution of a Fourth Generation Catalyst for the Amination and Thioetherification of Aryl Halides
- (2008) John F. Hartwig ACCOUNTS OF CHEMICAL RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now